Learn about some of the technical considerations for selecting antibodies during lateral flow assay development.
Nina Garrett, Head of Assay Development, looks at the technical considerations when starting a lateral flow project.
mHealth Software Regulation: part II: Regulations within the USA mHealth market, the largest diagnostic market.
mHealth Software Regulation: part I: European regulation surrounding the rapid growing mHealth market.
“Early adopters such as triathletes are at the pointy end of this drive towards consumer health diagnostics.”
A few considerations to think about when wanting to maximise profit for your lateral flow rapid test.
What barriers can be broken down to aid recruitment and retention of clinical trial volunteers?
Octylphenol ethoxylates are now included in the Annex XIV of REACH. What does it mean for LFIAs that use OPEs?
See how rapid near-patient tests and data solutions can facilitate a patient centric approach to clinical trials.
Switching lateral flow manufacturer doesn’t have to be a headache and could change the prospects of your business.
Patient-experience and clinician-needs should be at the heart of monitoring drug therapy. Is there a device that aid these patient and clinician needs?